CSL Behring corporate brochure (English, 1.25MB)
CSL Behring corporate brochure (German, 1.25MB)
CSL Behring global product portfolio (PDF, 30KB)
Interactive product pipeline
|
CSL Behring Fact Sheet
Resources -
Download Fact Sheet (129kb)
 CSL Behring is a leader in the plasma protein therapeutics industry. Committed to saving lives and improving the quality of life for people with rare and serious diseases, the company manufacturers and markets a range of plasma-derived and recombinant therapies worldwide. CSL Behring therapies are indicated for the treatment of coagulation disorders including hemophilia and von Willebrand disease, primary immune deficiencies and inherited respiratory disease. The company’s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic diseases in newborns. CSL Behring operates one of the world’s largest plasma collection networks, ZLB Plasma. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company headquartered in Melbourne, Australia. For more information, visit www.cslbehring.com. | | | | | | Peter Turner | Paul Perreault | Val Romberg | Gordon Naylor | | President | Exec. VP,
Commercial Operations | Sr. VP,
Global R&D | Exec VP, Plasma, Planning and Logistics | | Employees | 8,400 employees in 19 countries | | Headquarters | King of Prussia, Pennsylvania, USA | | Plasma Collection | ZLB Plasma is one of the world’s largest plasma collection
organizations. The company operates more than 70
collection centers in the United States and Germany.
Headquarters are in Boca Raton, Florida. Testing laboratories
are located in Knoxville, Tennessee and in Goettingen, Germany. | | Manufacturing | Bern, Switzerland: center of excellence for immunoglobulins; Marburg, Germany: center of excellence
for coagulation products; Kankakee, Illinois, USA: center of excellence for Alpha1-proteinase inhibitor | | R&D | CSL integrated R&D includes facilities in Marburg, Germany; Bern, Switzerland; King of Prussia, Pennsylvania,
USA; Tokyo, Japan; and Broadmeadows and Parkville, Australia | | 2007/08 Sales | Approximately U.S. $2.5 billion | Return to Top Plasma Collection Business ZLB Plasma is one of the world’s largest plasma collection organizations. The company operates more than 70 collection centers in the United States and Germany. Headquarters are in Boca Raton, Florida. Testing laboratories are located in Knoxville, Tennessee and in Goettingen, Germany. Return to Top Therapeutic Focus | Coagulation | Therapies to treat bleeding disorders including hemophilia and von Willebrand disease | | Immune Deficiencies | Products used to treat immunological disorders, such as primary immune deficiency, Idiopathic Thrombocytopenic Purpura (ITP), Guillain-Barré Syndrome and hemolytic disease of the newborn | | Pulmonary | Therapies used to treat Alpha1-Antitrypsin Deficiency (genetic condition resulting in liver and lung failure) | | Critical Care | Critical care products for Hereditary Angioedema, treatment of shock and burns, and fluid replacement therapy | | Wound Healing | Therapies used in surgery and the treatment of wounds to facilitate healing | Return to Top
|